XML 66 R51.htm IDEA: XBRL DOCUMENT v3.24.1
Share-Based Compensation (Tables)
 12 Months Ended
Feb. 03, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of share-based compensation expense recognized under all of the Company's stock plans
The following summarizes the share-based compensation expense recognized under all of the Company’s stock plans (in thousands):
Year Ended
Feb 3, 2024Jan 28, 2023Jan 29, 2022
Stock options$713 $2,709 $3,528 
Stock awards/units19,369 17,478 17,385 
ESPP164 208 206 
Total share-based compensation expense$20,246 $20,395 $21,119 
Schedule of stock option activity under all of the Company's stock plans
The following summarizes the stock option activity under all of the Company’s stock plans:
Number of SharesWeighted Average
Exercise Price		Weighted Average
Remaining
Contractual
Term (Years)		Aggregate
Intrinsic
Value ($000’s)
Options outstanding at January 28, 20232,569,629 $16.24   
Granted— $—   
Exercised(262,402)$15.49   
Forfeited(11,175)$14.32   
Expired(155,450)$25.19   
Options outstanding at February 3, 20242,140,602 $15.69 4.83$16,136 
Exercisable at February 3, 20242,140,602 $15.69 4.83$16,136 
Schedule of nonvested stock awards/units activity under all of the Company's stock plans
The following summarizes the nonvested stock awards/units activity under all of the Company’s stock plans:
Number of Awards/UnitsWeighted Average Grant Date Fair Value
Nonvested at January 28, 20232,340,292 $17.81 
Granted1,280,124 $17.10 
Vested(1,458,039)$14.51 
Forfeited(214,521)$20.20 
Nonvested at February 3, 20241,947,856 $19.56 
Schedule of activity for nonvested performance-based units and nonvested market-based units
The following summarizes the activity for nonvested performance-based units and nonvested market-based units included in the above:
Performance-Based UnitsMarket-Based Units
Number of UnitsWeighted Average Grant Date Fair ValueNumber of UnitsWeighted Average Grant Date Fair Value
Nonvested at January 28, 2023612,627 $20.14 946,787 $14.75 
Granted1
340,042 $18.14 281,487 $12.06 
Vested1
(391,388)$20.02 (505,494)$6.38 
Forfeited(184,365)$20.34 — $— 
Nonvested at February 3, 2024376,916 $18.36 722,780 $19.55 
______________________________________________________________________
1As a result of the achievement of certain market-based vesting conditions, there were 145,003 shares that vested in addition to the original target number of market-based shares granted in fiscal 2021.
Schedule of assumptions used for market-based nonvested stock units The following assumptions were used for the grants:
Year Ended
Valuation AssumptionsFeb 3, 2024Jan 28, 2023Jan 29, 2022
Risk-free interest rate3.7 %2.8 %0.6 %
Expected stock price volatility59.7 %71.3 %78.4 %
Expected dividend yield— %— %— %
Expected life of market-based awards2.7 years2.7 years3.5 years
Schedule of weighted average assumptions used for ESPP
The fair value of stock compensation expense associated with the Company’s ESPP was estimated on the date of grant using the Black-Scholes option-pricing valuation model with the following weighted average assumptions used for grants:
Year Ended
Valuation AssumptionsFeb 3, 2024Jan 28, 2023Jan 29, 2022
Risk-free interest rate5.2 %2.4 %0.0 %
Expected stock price volatility40.8 %55.4 %50.4 %
Expected dividend yield5.8 %5.3 %2.4 %
Expected life of ESPP options3 months3 months3 months